Navy Petty Officer Second Class Ferdinand Chua, hospital corpsman with 3d Marine Logistics Group, extracts the serum separated from a blood sample during a research study conducted by Naval Medical Research Unit on Camp Kinser, Okinawa, Japan, June 15, 2021. The study was conducted amongst active duty Navy and Marine Corps personnel to investigate the percentage of Marines and Sailors previously infected with SARS-CoV-2, the virus that causes COVID-19. The purpose of the study is to understand how widespread COVID-19 infections are throughout the United States Indo-Pacific Command. 3
Navy Petty Officer Second Class Ferdinand Chua, hospital corpsman with 3d Marine Logistics Group, extracts the serum separated from a blood sample during a research study conducted by Naval Medical Research Unit on Camp Kinser, Okinawa, Japan, June 15, 2021. The study was conducted amongst active duty Navy and Marine Corps personnel to investigate the percentage of Marines and Sailors previously infected with SARS-CoV-2, the virus that causes COVID-19. The purpose of the study is to understand how widespread COVID-19 infections are throughout the United States Indo-Pacific Command. 3d MLG, based out of Okinawa, Japan, is a forward deployed combat unit that serves as III MEF’s comprehensive logistics and combat service support backbone for operations throughout the Indo-Pacific area of responsibility.
Size: 1291px × 1936px
Photo credit: © Operation 2021 / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: 3d, coronavirus19, corpsman, covid, medical, mlg, research
